Rescue strategies combining ultra-protective ventilation and veno-venous ECMO in a patient with near-drowning-related severe ARDS: a case report and literature review Authors: Li Zhang, Zhekang Peng, Dingdeng Wang, Fei Tian, Xingguang Qu, Zhaohui Zhang, Gaosheng Zhou Published: 2026 ABSTRACT AbstractBackgroundDrowning can lead to acute respiratory distress syndrome (ARDS), which is associated with high mortality and poses substantial clinical management challenges. Ultra-protective ventilation strategy combined with veno-venous extracorporeal membrane oxygenation (VV-ECMO) present a viable alternative, yet evidence supporting these strategies in drowning-related ARDS patients remains scarce.Case presentationThis case report describes an 18-year-old female who experienced cardiac arrest following near-drowning. After the return of spontaneous circulation, the patient developed severe pulmonary edema leading to ARDS. VV-ECMO was initiated, resulting in a significant improvement in the Horowitz coefficient. Using a combination of VV-ECMO and an ultra-protective ventilation strategy with a lowest tidal volume of 2.8 ml/kg (predicted body weight, PBW), the patient’s lung condition improved significantly. Static lung compliance rose from 11 ml/cm H₂O to 46 ml/cm H₂O. The patient was successfully weaned from VV-ECMO on Day 15, extubated on Day 27, and eventually discharged with no obvious pulmonary sequelae.ConclusionThe present case indicate that combining ultra-protective ventilation and VV-ECMO may be an effective approach for managing severe near-drowning-related ARDS by improving lung function and increasing the likelihood of successful extubation. This strategy minimizes ventilator-induced lung injury (VILI) while optimizing oxygenation, providing a new perspective for treating similar patients. Further studies are needed to validate its efficacy and optimize treatment protocols.Keywords: ARDS, Near-drowning, Ultra-protective ventilation, VV-ECMO, Case report Introduction Acute respiratory distress syndrome (ARDS) is a serious clinical syndrome characterized by the onset of hypoxemia refractory to supplemental oxygen, bilateral pulmonary edema and reduced respiratory system compliance. It can result from various lung injuries, such as pneumonia, sepsis, and aspiration [1]. Among these, drowning-related ARDS presents unique challenges due to the complex pathophysiology of water aspiration, which leads to alveolar epithelial damage, surfactant dysfunction, and intense inflammatory responses [2]. Despite advances in critical care, the mortality rate of severe ARDS remains high, particularly in cases resulting from drowning [3, 4]. Mechanical ventilation is a cornerstone of ARDS treatment, but conventional strategies can exacerbate ventilator-induced lung injury (VILI) through mechanisms such as barotrauma, volutrauma, and atelectrauma. To mitigate these risks, lung-protective ventilation strategies, including low tidal volume (VT) and moderate positive end-expiratory pressure (PEEP), have become standard practices [5]. However, in patients with severe ARDS, even these strategies may be insufficient to maintain adequate oxygenation and prevent further lung injury. This has led to the emergence of ultra-protective ventilation strategies [6], which involve very low VT (≤ 4 ml/kg predicted body weight), high PEEP, and permissive hypercapnia, often combined with extracorporeal membrane oxygenation (ECMO) to ensure sufficient gas exchange. Veno-venous ECMO (VV-ECMO) has gained prominence as a rescue therapy for patients with severe ARDS, providing temporary pulmonary support while allowing the lungs to recover [7]. When combined with ultraprotective ventilation, VV-ECMO may further reduce the risk of VILI by minimizing mechanical stress. However, the application of this combined approach in patients with drowning-related ARDS has not been extensively studied, and its impact on lung function recovery and extubation success remains unclear. This case report describes the successful management of an 18-year-old female with drowning-related severe ARDS treated with ultra-protective ventilation and VV-ECMO. The patient, who experienced cardiac arrest following drowning, developed profound hypoxemia and respiratory failure despite conventional therapies. The implementation of ultra-protective ventilation (VT lowest to 2.8 ml/kg predicted body weight, PEEP ≥ 10 cmH2O, and permissive hypercapnia) alongside VV-ECMO led to significant improvements in lung function, ultimately enabling successful weaning from mechanical ventilation and ECMO. This case underscores the potential benefits of this combined strategy in patients with drowning-related ARDS and highlights the need for further research to optimize its application. Case presentation An 18-year-old female was admitted to our hospital following cardiac arrest after a near-drowning incident in the Yangtze River. The patient was previously healthy with no family history of genetic disease. She had been submerged for approximately 15 min before being rescued. When discovered by emergency medical service (EMS) personnel, the patient was in cardiac arrest. Immediate resuscitative measures, including endotracheal intubation and cardiopulmonary resuscitation (CPR), were performed. Afterward, the patient was rapidly transported to the emergency department in our hospital, where advanced cardiovascular life support was continued for approximately 30 min until the return of spontaneous circulation (ROSC) was achieved. The patient was admitted urgently to the emergency intensive care unit (EICU). On admission, the patient had a core body temperature of 35.4 °C, a heart rate of 120 beats per minute, and a respiratory rate of 34 breaths per minute. The patient’s blood pressure was 94/50 mmHg (supported by 0.75 µg/kg•min norepinephrine). The patient had been intubated by the prehospital emergency medical services team and placed on mechanical ventilation with 100% oxygen, which maintained the patient’s peripheral capillary oxygen saturation at 96%. Suction produced a large amount of red discharge from the tracheal cannula. The patient was 158 cm tall and weighed 48 kg. andwas comatose and unresponsive. Herpupils were bilaterally dilated to approximately 4.0 mm, without light reflexes. A chest radiograph revealed significant moist rales in both lungs. Following the discontinuation of sedative medications, a detailed neurological examination revealed that the patient’s neural reflexes were significantly hypoactive. The results of the patient’s serial investigations are shown in Table 1. Chest computed tomography (CT) showed bilateral and multiple mottled shadows. Pleural effusion was absent (Fig. 1A and B). Point-of-care lung ultrasound revealed massive pulmonary edema, as shown by the presence of numerous B-lines (Fig. 1C). Within 24 h of admission to the EICU, the patient’s Acute Physiology and Chronic Health Evaluation-II (APACHE-II), Sequential Organ Failure Assessment (SOFA), and Murray Lung Injury (Murray) scores were 22, 13, and 3.5, respectively. Table 1Clinical laboratory resultsItemReference valueDay 0Day 3Day 6Day 9Day 12Day 15WBC (109/L)3.5–9.510.323.835.498.6211.188.8HGB (g/L)115–1501449184949098PLT (109/L)125–30018351356689108CRP (mg/L)0–62.82139.45200.12160.03119.98104.18PCT (ng/mL)<0.01<0.0112.3674.7952.6290.6471.234ALT (U/L)7–40975843317551AST (U/L)13–35151165202144176116ALB (g/L)40–5524.5645.0930.9131.5933.3935.9GLU (mmol/L)3.9–6.124.4613.19.48.78.88.9LDH (IU/L)120–25065850813387451027483CK (IU/L)40–2001134253787947566CK-MB (U/L)0–25166138.825.719.518.211CTnI (ng/mL)<0.040.010.03<0.01//<0.01BNP (pg/mL)<1001018769//54Ca2+ (mmol/L)2.11–2.521.562.232.542.302.322.33K+ (mmol/L)3.5–5.32.745.04.33.524.163.8BUN (mmol/L)3.1–8.84.830.745.353.653.53.78CREA (umol/L)41–73542153322036PT (s)11.0–15.016.820.718.314.613.615.4APTT (s)32.0–45.058.361.185.741.449.159.7Fib (g/L)2.0–4.01.922.772.045.634.541.53NSE (mmol/L)0-16.374.472.248.026.725.123.9PH7.167.287.257.37.347.297.31PO2 (mmHg)111.3589.5863.55235.43249.17230.94297.26PCO2 (mmHg)55.0449.0353.550.3348.8245.8647.9P/F ratio111.3599.5363.55----Lac (mmol/L)19.74.43.11.91.41.11.2Abbreviations: WBC white blood cell, HGB hemoglobin, PLT platelet, CRP C-reactive protein, PCT procalcitonin, ALT alkaline phosphatase, AST aspartate transaminase, ALB albumin, GLU glucose, LDH lactate dehydrogenase, CK creatine kinase, CK-MB creatine kinase myocardial band, CTnI cardiac troponin I, BNP brain natriuretic peptide, Ca2+ calcium ion, K+ potassium ion, BUN blood urea nitrogen, CREA creatinine, PT prothrombin time, APTT activated partial thromboplastin time, Fib fibrinogen, NSE neuron-specific enolase, PH potential of hydrogen, PO2 partial pressure of oxygen, PCO2 partial pressure of carbon dioxide, P/F partial pressure of oxygen over fraction of inspired oxygen, Lac lactate Clinical laboratory results Abbreviations: WBC white blood cell, HGB hemoglobin, PLT platelet, CRP C-reactive protein, PCT procalcitonin, ALT alkaline phosphatase, AST aspartate transaminase, ALB albumin, GLU glucose, LDH lactate dehydrogenase, CK creatine kinase, CK-MB creatine kinase myocardial band, CTnI cardiac troponin I, BNP brain natriuretic peptide, Ca2+ calcium ion, K+ potassium ion, BUN blood urea nitrogen, CREA creatinine, PT prothrombin time, APTT activated partial thromboplastin time, Fib fibrinogen, NSE neuron-specific enolase, PH potential of hydrogen, PO2 partial pressure of oxygen, PCO2 partial pressure of carbon dioxide, P/F partial pressure of oxygen over fraction of inspired oxygen, Lac lactate Chest CT on admission showing bilateral mottled shadows and no pleural effusion (A, B). Point-of-care lung ultrasound revealed many B-lines in multiple locations and “fragmentation” in both lower lungs (C) The patient was placed on continuous invasive mechanical ventilation (IMV) and received restricted intravenous rehydration along with norepinephrine to support the patient’s respiratory and circulatory function. Since the patient inhaled large amounts of sewage containing grass seeds and weeds, which could lead to pneumonia, we administered preventative antibiotics, including piperacillin-tazobactam and voriconazole, based on clinical experience. The infectious agent was investigated prior to initiating broad-spectrum antibiotic therapy. Diagnostic laboratory assays, including blood, fecal, urinary, and bronchoalveolar lavage fluid (BALF) cultures, and metagenomic pathogen detection in blood and BALF, were conducted to swiftly identify possible infectious agents. Additionally, the patient received targeted temperature management to protect her brain from hypothermia. Nutritional support, blood glucose regulation, and symptomatic treatment were also provided. Chest X-ray and CT scans revealed infiltration without pleural effusion. Additionally, point-of-care lung ultrasound revealed several B-lines on both sides. The PaO2/FiO2 ratio was significantly lower than 300 mmHg when the patient received a PEEP of 12 cmH2O through mechanical ventilation. Based on these findings (Table 2) and the diagnostic criteria from the 2023 European Society of Intensive Care Medicine (ESICM) guidelines on ARDS [5], the diagnosis of ARDS was confirmed. Consequently, we implemented a protective lung ventilation strategy for this patient, which included administering low tidal volumes and adjusting appropriate levels of PEEP. To mitigate the inflammatory response associated with ARDS, we administered methylprednisolone. Once hemodynamically stable, the patient was initiated on prone positioning to enhance oxygenation. Table 2Diagnostic criteria for ARDSAcute onset within 1 week of known insult or new or worsening respiratory symptomsYESBilateral opacities on chest radiography or computed tomography not fully explained by effusions, lobar/lung collapse, or nodules or ultrasound reveals bilateral loss of lung aeration (multiple B lines and/or consolidations)YESPaO2/FiO2≤300 mmHg or SpO2:FiO2 ≤315 mmHg(SpO2 is ⩽97%)YESPEEP ⩾ 5 cm H2O(invasive mechanical ventilation )YES Diagnostic criteria for ARDS The PaO2/FiO2 ratio decreased to a low of 63 mmHg. After hypothermia therapy was stopped, the patient developed a high fever, reaching 39 °C, along with a significant increase in levels of inflammatory markers such as C-reactive protein (CRP) and procalcitonin (PCT). A follow-up chest CT scan (Fig. 2) revealed patchy exudates and consolidation in both lungs. Next-generation sequencing (NGS) of the BALF revealed infections with Klebsiella pneumoniae (10,325 sequences), Escherichia coli (6,760 sequences), Stenotrophomonas maltophilia (837 sequences), and Aeromonas hydrophila (235 sequences). The presence of NDM, OXA, and CTX antibiotic resistance genes was also detected. On the basis of the examination results and clinical features, the patient was suspected of developing drowning-related aspiration pneumonia, which had progressed to profound ARDS. Thus, we adjusted the antibiotic therapy to cefiderocol-avibactam based on the results of the pathogen examination. Image of the chest CT scan. On Day 3 (A, B), the exudation was diffuse; on Day 6 (C, D), after three days of ECMO support and treatment, the exudation was partially absorbed; on Day 12 (E, F) and Day 14 (G, H), the pulmonary state further improved; and on Day 59 (I, J), after 59 days of treatment, a chest CT scan revealed plaques and solid lesions Given the severe refractory hypoxemia (PaO2/FiO2 ratio < 80 mmHg) and despite maximal conventional lung-protective ventilation (tidal volume 6 mL/kg, PEEP 14 cmH2O, FiO2 1.0) and prone positioning, the patient received VV-ECMO, with a 21 Fr cannula in the right femoral vein for drainage and a 17 Fr cannula in the right internal jugular vein for return, at a blood flow rate of 4 L/min, a gas flow rate of 4 L/min, and an inspired oxygen fraction of 100%. In addition, sufficient sedation, pain relief, and muscle relaxants were provided. The ventilator settings were carefully adjusted on the basis of the driving pressure, and the respiratory mechanics were rigorously monitored (Table 3). To reduce the lung injury caused by the ventilator and allow the lungs to rest, ultra-protective ventilation strategies were implemented, with a total tidal volume of 200 mL, inspired oxygen fraction of 40%, respiratory rate of 10 breaths/min, and positive end-expiratory pressure of 12 cmH2O. The patient also received prone positioning ventilation therapy for more than 16 h per day. Anticoagulation during ECMO was maintained with heparin infusion and titrated to target an activated partial thromboplastin time (APTT) [8]. In addition, anticoagulation was monitored using APTT measurements drawn every 4–6 h [9]. Following this course of therapy, the patient’s body temperature and oxygenation improved gradually as the ECMO settings were progressively reduced. By the 15th day, the VV-ECMO was successfully evacuated from the patient. Table 3Ventilator and ECMO settingsECMOIMVBreathing MechanicsRotate speed(R/min)Flow(L/min)FDO2(%)Airflow velocity(L/min)VT(ml)FiO2(%)f(bpm)PEEP(cmH2O)Crs(ml/cmH2O)Rrs(cmH2O)DP(cmH2O) P plat (cmH2O)Day340004.31004.014040101027141222Day440004.11004.014040101011151323Day540004.21004.01404010101912919Day840004.11004.01804010823111422Day1040004.2803.02404515833101321Day1240004.1602.0280451584091321Day1538003.5210320401864671420Abbreviations: FDO2 fraction of inspired oxygen, VT tidal volume, FiO2 fractional inspired oxygen, f respiratory rate, PEEP positive end-expiratory pressure, Crs respiratory compliance, Rrs airway resistance, DP driving pressure, Pplat plateau pressure Ventilator and ECMO settings Abbreviations: FDO2 fraction of inspired oxygen, VT tidal volume, FiO2 fractional inspired oxygen, f respiratory rate, PEEP positive end-expiratory pressure, Crs respiratory compliance, Rrs airway resistance, DP driving pressure, Pplat plateau pressure On the 19th day after admission (the 4th day after ECMO evacuation), the patient experienced fever again, and blood cultures revealed A. hydrophila infection. After the antibiotics were adjusted to cefoperazone-sulbactam based on the susceptibility test results, the patient’s temperature returned to normal. On the 20th day, vital signs and general condition were stable, but owing to poor consciousness, the patient underwent percutaneous tracheostomy on the same day and successfully weaned off the ventilator on the 27th day after respiratory training. On the 30th day after admission, owing to poor consciousness, the patient was transferred to the neurosurgery department for short-term spinal cord electrical stimulation for further neurological function recovery. Excitingly, the patient was successfully aroused after one week and could open her eyes voluntarily and follow commands, but the responses were still sluggish. On the 59th day, a follow-up chest CT scan (Fig. 2) revealed no pulmonary fibrosis or other imaging signs in the lungs. The patient was discharged and returned home one week later. A month after discharge, a telephone follow-up confirmed that the patient was receiving daily rehabilitation without common ECMO or ARDS-related complications such as pneumothorax or mediastinal emphysema. The patient achieved a cerebral performance category (CPC) score of 2–3 at the 1-month follow-up. Finally, the total timeline is shown in Table 4. Table 4Total timelineTimeClinical manifestationKey findings/InterventionDay 0Admission, Drowning, Cardiac arrest, CPR, ARDSP/F ratio 111.35, Lac 19.7, IMV, PPVDay 3Respiratory failureP/F ratio 63, T 39 °C, VV-ECMODay 4High driving pressureTidal Volume 2.8 ml/PBWDay 15Evacuated ECMO-Day 20-TracheotomyDay 27-Weaning from the ventilatorDay 30GCS: E2VtM4Short-term spinal cord electrical stimulationDay 37GCS: E4VtM6-Day 59-Tracheostomy tube cappingDay 66Discharge-Abbreviations: CRP ARDS, P/F partial pressure of oxygen over fraction of inspired oxygen (mmHg), Lac lactate (mmol/L), IMV invasive mechanical ventilation, PPV prone position ventilation, T temperature, VV-ECMO veno-venous extracorporeal membrane oxygenation, PBW predicted body weight, GCS Glasgow Coma Scale Total timeline Abbreviations: CRP ARDS, P/F partial pressure of oxygen over fraction of inspired oxygen (mmHg), Lac lactate (mmol/L), IMV invasive mechanical ventilation, PPV prone position ventilation, T temperature, VV-ECMO veno-venous extracorporeal membrane oxygenation, PBW predicted body weight, GCS Glasgow Coma Scale Discussion In this case, we present a patient who developed a complex infection and severe ARDS following near-drowning and was successfully rescued by ultra-protective ventilation during VV-ECMO. To our knowledge, few reports have described this specific clinical scenario. We aim to highlight the potential benefits of combining these two treatment methods to help readers better address similar clinical challenges. ARDS is a serious condition caused by various lung injuries, resulting in widespread lung damage and severe hypoxemia, which is always associated with high patient mortality. The pathophysiology of ARDS has three key manifestations: reduced lung volume, decreased lung compliance, and a mismatch in the ventilation‒perfusion ratio [10]. Despite these similarities, the pathophysiology of ARDS caused by drowning still has its own characteristics. In addition to inhaling water and debris, which can directly damage alveolar capillary membranes, the extent of damage also depends on the type of aspirated fluid [11]. Aspiration by freshwater always leads to rapid pulmonary edema due to osmotic changes [12] and can result in surfactant washout and alveolar collapse, thus contributing to the progression of ARDS. However, seawater aspiration can induce more severe lung injury because of hyperosmolarity, which may inactivate alveolar surfactant [13, 14]. In addition, lung damage after drowning includes not only direct physical and chemical effects but also secondary infections caused by inhaled microorganisms [15]. Infections can exacerbate the alveolar inflammatory response, further damaging the alveolar epithelium and endothelial cells and leading to a more complex pathological process. It presents unique challenges because of its complex pathophysiology, including alveolar epithelial damage, surfactant dysfunction, and intense inflammatory responses. These factors contribute to the rapid progression of respiratory failure and high mortality and make it difficult for traditional ventilation strategies to satisfy the needs of patients [16]. Recent studies have demonstrated that ultra-protective ventilation strategies can effectively reduce VILI and improve the prognosis of patients with ARDS [17]. Moraes et al. reported that reducing the tidal volume from 6 mL/kg to 3 mL/kg resulted in less damage to alveolar epithelial cells in rats with ARDS [18]. Even in veno-arterial ECMO patients with refractory cardiogenic shock, ultra-protective strategies have been shown to reduce lung injury, increase oxygenation, and minimize complications from mechanical ventilation [19]. In this case, we utilized a tidal volume as low as 2.8 mL/kg, which likely contributed to the recovery of the patient’s lung tissues. However, ultra-protective ventilation strategies may also result in hypercapnia and an increased respiratory rate while alleviating lung injury and improving prognosis. In recent years, the use of ECMO for severe respiratory failure has increased significantly, particularly during the COVID-19 pandemic, when it played a crucial role in treating patients with critical respiratory distress [20, 21]. ECMO enables efficient gas exchange, improving oxygenation and reducing carbon dioxide levels. Furthermore, it allows for the lung tissues to heal and recover function. Additionally, ECMO can reduce the lung damage associated with mechanical ventilation and potentially alleviate or prevent the harmful effects of intensive lung-protective ventilation strategies. The practice of ultra-protective ventilation combined with VV-ECMO in clinical situations appears promising. Many studies have indicated that combining ECMO with ultra-protective ventilation is beneficial for severe ARDS caused by COVID-19 [22–24]. Huang et al. reported that VV-ECMO facilitated ultra-protective ventilation in patients with severe pneumocystis pneumonia and prevented the progression of spontaneous pneumothorax, subcutaneous emphysema, and secondary pneumothorax [25]. Some researchers have shown that this approach could benefit patients with ARDS caused by exposure to high-temperature smoke; these patients received VV-ECMO combined with prone ventilation for more than 12 h and were successfully discharged with no obvious respiratory symptoms [26]. In addition, a study [17] revealed that combining ultra-protective ventilation strategies with VV-ECMO in patients with severe ARDS could significantly downregulate the levels of monocyte chemoattractant protein-1 (MCP-1) and plasma soluble receptors of advanced glycation end-products (sRAGE) after 7 days, thus alleviating pulmonary trauma. In addition, the treatment significantly reduced the plateau pressure, expiratory volume and driving pressure of the patients, leading to a reduction in VILI. In this case report, we describe an 18-year-old female patient with near-drowning-related ARDS who was successfully rescued by a combination of ultra-protective strategies and VV-ECMO and who recovered with no complications, including pneumothorax, mediastinal emphysema, or sequelae such as pulmonary fibrosis or proliferative lesions. Owing to the limited literature in this context, the outcome of this patient is quite valuable and indicates that the approach may benefit other patients with similar conditions. In alignment with previous literature [27], the tidal volume, respiratory rate, plateau pressure, and driving pressure we used in this case were lower than those typically used in protective ventilation strategies during VV-ECMO. Notably, in our case, the ultra-protective ventilation settings used an even lower tidal volume of 2.8 mL/kg with a more stable plateau pressure and driving pressure. Although deep sedation and neuromuscular blocking agents may lead to muscle respiratory weakness and result in delayed weaning of the ventilator, the treatment facilitated the absorption of pulmonary infiltrates and recovery of respiratory strength. The protracted recovery of mental status and limb muscle strength was likely due to postcardiac arrest anoxic brain injury. The effectiveness of using ultra-protective ventilation strategies together with ECMO is what we emphasize in this case, and we recommend that clinicians consider this approach for patients with drowning-related ARDS, although the optimal mechanical ventilation settings during ECMO have not been established. Further research is needed to reduce VILI and improve the recovery of pulmonary function. Conclusions In conclusion, this case illustrates the potential benefits of combining ultra-protective ventilation with VV-ECMO for the management of severe near-drowning-related ARDS. The patient’s successful recovery highlights the importance of minimizing VILI and optimizing gas exchange through this multimodal approach. While further research is needed to validate these findings, this case provides valuable insights into the treatment of a challenging and understudied condition. Acknowledgements The authors thank the patient who kindly volunteered to participate in this study. Abbreviations Acute respiratory distress syndrome Extracorporeal membrane oxygenation Veno-venous extracorporeal membrane oxygenation Predicted body weight Ventilator-induced lung injury Tidal volume Positive end-expiratory pressure Emergency medical service Cardiopulmonary resuscitation Return of spontaneous circulation Emergency intensive care unit Computed tomography Acute physiology and chronic health evaluation-II Sequential organ failure assessment White blood cell Hemoglobin Platelet C-reactive protein Procalcitonin Alkaline phosphatase Aspartate transaminase Albumin Glucose Lactate dehydrogenase Creatine kinase Creatine kinase myocardial band Cardiac troponin I Brain natriuretic peptide Calcium ion Potassium ion Blood urea nitrogen Creatinine Prothrombin time Activated partial thromboplastin time Fibrinogen Neuron-specific enolase Potential of hydrogen Partial pressure of oxygen Partial pressure of carbon dioxide Partial pressure of oxygen over fraction of inspired oxygen Lactate Invasive mechanical ventilation Bronchoalveolar lavage fluid European society of intensive care medicine Next-generation sequencing Cerebral performance category Fraction of inspired oxygen Fractional inspired oxygen Respiratory rate Respiratory compliance Airway resistance Driving pressure Plateau pressure Prone position ventilation Temperature Glasgow coma scale Monocyte chemoattractant protein-1 Soluble receptors of advanced glycation end-products Authors’ contributions L.Z. and Z.P.: data collection and manuscript writing. D.W. and F.T.: provision of study materials or patients. X.Q. G.Z. and Z.Z.: conception, design, and administrative support. All authors have read and agreed to the published version of the manuscript. Funding Not applicable. Data availability The original contributions presented in the study are included in the article/Supplementary Materials; further inquiries can be directed to the corresponding author. Declarations Ethics approval and consent to participate Not applicable. Consent for publication Written informed consent for publication of the patient’s clinical details and any potentially identifying images was obtained from the patient prior to submission. The authors confirm that appropriate consent procedures were followed, and the consent form is held on file. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Li Zhang and Zhekang Peng contributed equally to this work. Contributor Information Zhaohui Zhang, Email: zhangzhaohui0316@163.com. Gaosheng Zhou, Email: gszhou2012@163.com. References Associated Data Data Availability Statement The original contributions presented in the study are included in the article/Supplementary Materials; further inquiries can be directed to the corresponding author.